ADAA members receive a complimentary annual online subscription to Depression and Anxiety. With an impact factor of 5.004, this journal ranks 19 of 140 in psychiatry journals and 10 of 76 in psychology journals.
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online only as of January 2013. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.
A priority is placed on papers focusing on treatment, as well as those providing cutting-edge reviews of key areas and issues, in order to enhance the clinical evaluation and care of individuals struggling with the effects of these disorders. All submissions are peer-reviewed; there is no handling or publishing fee.
NOTE: You must be a current member to log in. If you have questions about your login, please contact ADAA Membership.
Please note: Three open-access journals, the Journal of Depression & Anxiety (OMICS); Anxiety and Depression Research (Herbert Publications); and Annals of Depression and Anxiety (Austin Publishing) are not affiliated with ADAA. These publishers require payment of a handling or submissions fee from authors; find information about these fees on their websites. These publications are not related to Depression and Anxiety, the official ADAA journal.
The following articles from Volume 33 Issue 10 (October 2016) have been posted on the journal website.
2015 ADAA Scientific Research Symposium
Psychobiology of the Intersection and Divergence of Depression and Anxiety
Diego A. Pizzagalli PhD
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials
William A. Carlezon Jr. PhD, Andrew D. Krystal MD, MS
The Role of BDNF in the Development of Fear Learning
Iva Dincheva PhD, Niccola B. Lynch, Francis S. Lee MD, PhD
Amygdala–Cortical Connectivity: Associations With Anxiety, Development, and Threat
Andrea L. Gold PhD, Tomer Shechner PhD, Madeline J. Farber BA, Carolyn N. Spiro BA, Ellen Leibenluft MD, Daniel S. Pine MD, Jennifer C. Britton PhD
Treatment for Anhedonia: A Neuroscience Driven Approach
Michelle G. Craske PhD, Alicia E. Meuret PhD, Thomas Ritz PhD, Michael Treanor PhD, Halina J. Dour MA
Treatment and Prevention of Depression and Anxiety in Youth: Test of Cross-Over Effects
Judy Garber PhD, Steven M. Brunwasser PhD, Argero A. Zerr PhD, Karen T.G. Schwartz BS, Karen Sova BS, V. Robin Weersing PhD
The following articles from Volume 33 Issue 9 (September 2016) have been posted on the journal website.
From the ADAA President
Karen Lynn Cassiday PhD, ACT, President, ADAA
Psychotherapy versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments
Daniel J. Lee MD, Carla W. Schnitzlein DO, Jonathan P. Wolf MD, Meena Vythilingam MD, Ann M. Rasmusson MD, Charles W. Hoge MD
Patterns of Change in Response to Prolonged Exposure: Implications for Treatment Outcome
Joshua D. Clapp PhD, Joshua J. Kemp MS, Keith S. Cox PhD, Peter W. Tuerk PhD
Individualized Yoga for Reducing Depression and Anxiety, and Improving Well-Being: A Randomized Controlled Trial
Michael de Manincor, Alan Bensoussan, Caroline A. Smith, Kylie Barr, Monica Schweickle, Lee-Lee Donoghoe, Suzannah Bourchier, Paul Fahey
A Brief Ecological Momentary Intervention for Generalized Anxiety Disorder: A Randomized Controlled Trial of the Worry Outcome Journal
Lucas S. LaFreniere BA, Michelle G. Newman PhD